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Abstract
Background: Most patients with congenital heart disease (CHD) reach adulthood thanks to
the successful efforts of cardiac surgeons. However, sudden cardiac deaths are significantly
more prevalent in this population, and survival is reduced when compared to the general
population. The aim of this study is to define the prognostic value of selected clinical parame-
ters to predict mortality in adult CHD patients referred to the specialist outpatient centre. The
following parameters were analyzed as potential predictors of long-term survival: complexity of
heart defect, past surgical intervention, heart failure (functional class according to NYHA > I),
cyanosis, age and gender.
Methods: We analyzed data gathered from 1,304 patients (568 male) aged 18 to 72 (mean
29.4 ± 10.6) between 1995 and 2004. Mean duration of follow-up was 3.52 ± 1.83 years.
Results: During follow-up, 29 deaths were recorded (2.2%). Higher mortality was found in the
group of patients with complex as oppposed to simple CHD (28 [6.7%] vs. 1 [0.1%]; p = 0.00001),
in subjects without surgical correction as opposed to those operated on (21 [6.1%] vs. 8 [0.8%],
p = 0.00001). General survival was 99.1% at two years and 96.6% at five years. In univariate
survival analysis, all single clinical variables except patient gender were associated with
increased risk of death (p = 0.00001 for all). All patients who died presented with heart
failure. In multivariate analysis, the independent predictor of mortality was cyanosis (heart
rate 38.1). Complexity of lesion (heart rate 6.4) represented a relative risk factor.
Conclusions: Heart failure and cyanosis are negative predictors of survival in adult patients
with CHD. Complexity of the lesion increases the relative risk of mortality. Past cardiac
surgery is associated with better survival, but, as with age and gender, it is not a significant
prognostic factor. (Cardiol J 2009; 16, 4: 341–347)
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Introduction
Most adult patients with congenital heart dis-
ease (CHD) survive only thanks to the successful
efforts of paediatricians and cardiac surgeons.
A couple of decades ago, most such patients
died in childhood. Thus there were no adults pre-
senting with CHD and typical problems associated
with new a chronic clinical syndrome characterized
by the presence of residual defects and post-sur-
gery complications. The natural history of such cor-
rected CHD is also unknown, as survivors vary
widely, and surgical techniques evolve with time.
Today’s mean age of patients with CHD does not
exceed 40 [1]. The incidence of sudden death in this
population is 25–100 times higher than in the gen-
eral population, and fatal events are observed even
in subjects in their twenties [2]. Survival analysis
in patients with CHD is difficult due to methodolo-
gy issues and the fact that study groups are rela-
tively small. Survival data has been published for
certain heart defects, particularly when corrected
using specific surgical methods [3–6]. There have
however been few reports on survival of heteroge-
neous populations of patients from single, large
reference clinical centres [2, 7]. A broad population-
based approach to survival analysis is, in our opin-
ion, highly clinically relevant as it may reveal po-
tential risk factors for mortality. Knowing these
would help clinicians to identify subgroups at risk
and provide them with special care.
The aim of this study is to define the prognos-
tic value of selected clinical parameters in adult
CHD patients referred to the specialist outpatient
centre. The following parameters were analyzed as
having potential impact on long-term survival: com-
plexity of heart defect, surgical intervention in the
past, heart failure (functional class according to New
York Heart Association [NYHA] > I), cyanosis, age
and gender.
Methods
Our study involved 1,304 adult patients with
CHD (718 females), aged 18–72 (mean 29.4 ± 10.6),
followed between 1995 and 2004 in the Specialist
Outpatient Clinic for Adults with Congenital Heart
Disease, I Chair of Cardiology, University of Me-
dical Science in Poznan.
On presentation to the centre, a detailed his-
tory was taken focusing on the type of surgical re-
pair done in the past. After physical examination,
transthoracic echocardiography and standard 12-
-lead electrocardiogram were recorded. Based on
all the information, a diagnosis was made (or con-
firmed). Where a patient presented with more than
one cardiovascular anomaly, the dominant lesion
was used to classify the subject. Using the system
proposed by the Working Group of Congenital Heart
Disease in Adults of the British Society of Cardiol-
ogy (Somerville) [8], patients were classified as
having simple or complex CHD. Numbers of pa-
tients with simple and complex lesions, their de-
mography, types of operations performed, baseline
cyanosis and heart failure status are shown in
Table 1.
Patients were followed for between one and ten
years (mean 3.52 ± 1.83 years). Functional status
was assessed according to NYHA classification.
Patients at NYHA class > I were classified as pre-
senting with heart failure. Cyanosis was defined as
the presence of cyanotic skin and mucosa associat-
ed with arterial blood oxygenation £ 85% when
breathing normal air, when extracardiac causes
were excluded.
Statistical  analysis
Numerical variables are given as means and
standard deviations. Variables following normal dis-
tribution were compared using t-Student test,
others using the U Mann-Whitney test. Kaplan-
-Meier survival curves for subsets of patients pre-
senting certain characteristics were compared us-
ing log-rank test. Multivariate survival analysis
using Cox’s regression model was adopted to search
for mortality risk factors.
Results
There were 29 deaths (2.2%) during the mean
follow-up of 3.52 years. The incidence of deaths in
patients with particular types of CHD is shown in
Tables 2 and 3. Higher mortality was found in the
group of patients with complex vs. simple CHD
(28 [6.7%] vs. 1 [0.1%]; p = 0.00001) and in subjects
without surgical correction vs. those operated on
(21 [6.1%] vs. 8 [0.8%], p = 0.00001). Patients who died
were significantly older than those who survived
(41.9 ± 15.2 years vs. 29.1 ± 10.3 years; p = 0.0002).
General survival was 99.1% at two years and 96.6%
at five years (Fig. 1). In univariate survival analy-
sis, all single clinical variables, except gender, were
associated with increased risk of death (p = 0.00001
for all). Because all patients who died presented
with heart failure at baseline (NYHA > I), heart fail-
ure had to be excluded from multivariate survival
analysis using Cox’s regression model. In this
model the independent predictors of death were
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Table 1. Characteristics of study population of adults with coronary heart disease (CHD). Demographic
data, past cardiac surgery, presence of cyanosis and heart failure (NYHA > I) at baseline.
N Males Age No. of Age at No.of No. of
operated surgery cyanotic patients
patients patients  with baseline
NYHA > I
Simple CHD
ASD* 278 102 (36.6%) 32.6±12.9 200 (71.9%) 12.1±9.7 0 3 (1.08%)
VSD* 277 135 (48.7%) 27.6±9.3 226 (81.5%) 8.4±8.0 0 3 (1.08%)
PDA* 120 29 (24.1%) 27.5±9.5 116 (96.6%) 7.2±6.1 0 0
BAV 107 71 (66.3%) 26.9±6.7 36 (33.6%) 15.4±7.1 0 1 (0.93%)
PS 70 30 (42.8%) 27.5±9.1 49 (70%) 9.2±6.6 3(4.3%) 3 (4.3%)
PPVC 10 5 (50%) 31.2±14.5 10 (100%) 14.7±12.6 0 2 (20.0%)
Marfan 9 3 (33.3%) 26.8±9.8 1 (11.1%) 20.0 0 0
IPD 8 2 (25.0%) 32.0±11.8 0 0 0 0
MI 6 1 (16.6%) 24.7±3.8 2 (33.3%) 17.0±1.4 0 0
Williams 1 0 24.0 0 0 0 0
Total 886 378 (42.6%) 29.1±10.6 640 (72.2%) 9.9±8.5 3 (0.34%) 12 (1.35%)
Complex CHD
CoAo 106 61 (57.5%) 29.9±9.5 103 (97.2%) 10.2±7.0 0 7 (6.6%)
ToF 101 51 (50.5%) 27.8±7.7 96 (95.0%) 7.4±5.2 7 (6.9%) 9 (8.9%)
ASD I 38 17 (44.7%) 28.2±9.9 38 (100%) 11.8±10.8 0 3 (7.9%)
CAVC 32 12 (37.5%) 27.6±8.3 18 (56.2%) 5.7±3.0 8 (25.0%) 8 (25.0%)
Eisenmenger 27 6 (22.2%) 45.5±14.3 0 0 27 (100%) 27 (100%)
SAS 24 14 (58.3%) 30.0±10.3 15 (62.5%) 15.9±13.0 0 0
SV 23 11 (48.7%) 26.7±7.9 16 (69.6%) 8.9±4.2 20 (87.0%) 20 (87.0%)
Ebstein 20 15 (75%) 41.2±11.2 0 0 4 (20.0%) 9 (45.0%)
DTGA 19 9 (47.4%) 24.7±4.8 16 (84.2%) 3.5±3.2 7 (36.8%) 1 (11.1%)
VC 9 5 (55.6%) 26.9±7.1 9 (100%) 18.4±12.0 0 3 (37.5%)
CCTGA 8 6 (75.0%) 31.6±12.6 1 (12.5%) 45.0 2 (25.0%) 0
DORV 5 1 (20.0%) 23.4±3.0 5 (100%) 6.2±4.6 0 0
PA 3 0 22.3±1.2 2 (66.7%) 4.5±0.7 0 0
CCA 2 0 22.0±2.8 2 (100%) 4.5±0.7 0 0
BWG 1 0 28.0 1 (100%) 4.0 0 0
Total 418 208 (49.9%) 30.0±10.5 322 (77.0%) 9.5±8.1 75 (17.9%) 96 (23.0%)
*patients with normal pulmonary pressure; ASD — atrial septal defect type secundum and sinus venosus; ASD I — primum atrial septal defect;
BAV — bicuspid aortic valve; BWG — Bland-White’a-Garland syndrome; CCA — congenital coronary anomalies; CAVC — common atrio-ventricular
canal; CCTGA — congenitally corrected transposition of the great arteries; CoAo — coarctation of aorta; DORV — double outlet right ventricle;
DTGA — transposition of great arteries; Ebstein — Ebstein anomaly; Eisenmenger — Eisenmenger syndrome; IPD — idiopathic pulmonary dilatation;
Marfan — Marfan syndrome; MI — mitral insufficiency; PA — pulmonary atresia; PDA — persistent ductus arteriosus; PPVC — partial pulmonary
venous connection; PS — pulmonary stenosis; SAS — subvalvular aortic stenosis; SV — single ventricle; ToF — tetralogy of Fallot; VC — valve conduits;
VSD — ventricular septal defect; Williams — Williams syndrome
Table 2. Mortality rates in patients with simple congenital heart disease (CHD).
CHD type Overall ASD* VSD* PDA* BAV PS PPVC Marfan IPD MI Williams
No. of patients 886 278 277 120 107 70 10 9 8 6 1
Deaths (%) 1 (0.1%) 0 0 0 1 (0.93%) 0 0 0 0 0 0
*patients with normal pulmonary artery pressure; abbreviations — see Table 1
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cyanosis (heart rate 38.1) and complex lesion
(heart rate 6.4) represented a relative risk factor.
Age, gender and cardiac surgery in the past were
not found to predict mortality risk in long-term fol-
low-up (Table 4).
Discussion
During the follow-up (mean 3.5 years) 2.2% of
our patients died. The annual mortality of 1.4% re-
ported from Toronto [7] is thus significantly high-
er than observed in our series. On the other hand,
in a group of 3,589 patients followed for 25 years
by Silka et al. [2] only 115 deaths, i.e. slightly over
3%, were observed. Analysis of mortality and caus-
es of deaths in adult patients with CHD represent
a major challenge because a substantial number of
deaths occur outside the hospital [5, 9–11]. How-
ever, high clinical relevance of the problem prompts
many authors to search for predictors of mortality
in such patients. Cyanosis and age were found to
predict the risk of death in patients who survived
surgical repair of CHD [12]. Oechslin et al. [13]
showed that mortality in such patients was in-
creased by post-operative complications and severe
heart failure. In adults with CHD, incidence of sud-
den death was demonstrated to be higher in sub-
jects presenting with cyanosis and in survivors of
procedures involving systemic ventricle outflow
tract manipulation [2].
As noted above, we had to exclude heart fail-
ure from multivariate survival model. However, it
is obvious from our series that in patients who are
not functionally compromised, clinical outcome is
favourable compared to those with heart failure.
Most other authors report similar findings [2, 4, 10,
11, 14, 15]. Thus the ominous prognostic value of heart
failure in adults with CHD seems indisputable.
Nollert et al. [11] demonstrated heart failure
to be a negative predictor of survival in patients with
tetralogy of Fallot (ToF); Gatzoulis et al. [16] and
Table 3. Mortality rates in patients with complex
congenital heart disease (CHD).
CHD type No. of patients Deaths (%)
CoAo 106 0
ToF 101 2 (1.9%)
ASD I 38 0
CAVC 32 0
Eisenmenger 27 14 (51.8%)
SAS 24 0
SV 23 7 (30.4%)
Ebstein 20 1 (5%)
DTGA 19 1 (5.8%)
VC 9 1 (11.1%)
CCTGA 8 2 (25.0%)




Overall 418 28 (6.6%)
Abbreviations — see Table 1
Figure 1. Adult patients with coronary heart disease:
Kaplan-Meier survival curve based on ten-year follow-up.
Table 4. Predictors of mortality in adult patients with congenital heart disease: results of univariate and
multivariate survival analysis.
Univariate analysis Multivariate analysis
p Hazard ratio 95% confidence interval
Cyanosis 0.00001 0.00001 38.09 9.06–160.1
NYHA > I 0.00001 – – –
Lesion complexity 0.00001 0.34 6.42 0.69–59.43
Age (ten-year intervals) – 0.62 1.22 0.92–1.62
Cardiac surgery in the past 0.00001 0.75 1.00 0.39–2.57
Male gender 0.32 0.78 0.76 0.30–1.41
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van den Bosch et al. [17] demonstrated heart failure
to be a negative predictor of survival in patients with
single ventricle heart physiology. Heart failure has
been shown to be the leading cause of death in pa-
tients with transposition of the great arteries (DTGA)
who survived Mustard/Senning operations [18].
However, Ross-Heselink et al. [19] provided evi-
dence that the only negative predictor of survival
in such patients was an operation performed before
1970. In patients presenting with Ebstein anoma-
ly, one cause of death was found to be heart failure
resulting from dysfunction of the left ventricle due
to extensive fibrosis and inappropriate interaction
between left and right ventricle [20].
In our series, 28 deaths (96% of all deaths)
occurred in cyanotic patients. Not surprisingly, cy-
anosis was found to be the independent predictor
of mortality, a finding consistent with other reports.
In our cohort, the highest mortality (nine deaths)
was observed among patients with atrial septal de-
fect (ASD) presenting with pulmonary hyperten-
sion. High mortality is a well recognized feature of
patients with Eisenmenger syndrome [4, 10, 11, 14].
Using a multivariate model, Cantor et al. [9] dem-
onstrated arterial blood oxygenation lower than
80% to be one of the predictors of mortality in adults
with ASD.
Seven patients with ventricular septal defect
(VSD) and patent ductus arteriosus who died had
pulmonary hypertension. In both these lesions pul-
monary hypertension is known to develop earlier
in the course of the disease than in the case of ASD
[15]. Thus, affected subjects die younger [10].
A similar mechanism leading to cyanosis is one
of the main causes of death in patients with con-
genitally corrected transposition of the great arter-
ies with significant interventricular shunting (two
deaths in our series) [3].
The most frequent CHD presenting with cya-
nosis in adults is ToF. In our cohort there were two
deaths of patients with uncorrected defects of this
type. One of them was 48 years old, which is quite
exceptional bearing in mind that according to pub-
lished data only 5% of patients without surgical
correction reach the age of 40 [21]. The other fe-
male patient died soon after attempted complete
surgical repair of ToF. Thromboembolic complica-
tions typical of secondary polycytemia often lead to
fatal post-operative events in patients with such
lesions operated on late in the course of the disease
[11, 14, 15].
Seven deaths occurred in patients with single
ventricle heart physiology. The prognosis for sub-
jects affected with this type of CHD is poor; with-
out a Fontana operation ten-year survival is only
about 46%. It is highest in patients with common
chamber of left ventricle morphology [22].
In our cohort. only one female patient had un-
dergone a Fontana operation in the past. Although
most survivors of such operations present with
normal blood oxygenation, some patients develop
cyanosis as a consequence of residua and sequels
of the lesion, most frequently pulmonary shunts [7].
According to Gatzoulis et al. [16], as many as 38%
of patients after Fontana procedure require phle-
botomy. Another two patients in our group under-
went an unsuccessful Fontana operation; one had
VSD dilated, the other was left with pulmonary ar-
tery binding intact, and so the exact mechanism of
cyanosis could not be elucidated. Finally, two other
patients had only Blalock-Taussig systemic-pulmo-
nary shunts constructed, something known to pro-
duce only a very limited increase in pulmonary blood
supply (205) [23]. No other patients had undergone
surgical repair in childhood. Ammash et al. [24]
reported the results of long-term follow-up of 13 pa-
tients with uncorrected common ventricle heart
physiology at the mean age of 42 years. Over the
course of ten years, only one death was recorded.
Long-term follow-up of adults with Ebstein
anomaly indicates a rather favourable prognosis in
this type of CHD [25]. Only one death in a patient
with significantly reduced blood oxygenation was
recorded. Cyanosis was found to be one of the main
causes of mortality in such patients [20].
There is no consensus among experts as to the
main causes of mortality in adult patients with CHD.
According to Daliento et al. [10], 29% of deaths re-
sult from bleeding complications, 23% from heart
failure, 3% from cerebral abscesses, 5% are relat-
ed to pregnancy, 2% are associated with post-op-
erative complications and in 7% the cause is unde-
termined. Sudden death is believed to be equally
frequently caused by acute pulmonary thrombosis
and arrhythmic events. According to Niwa et al. [14],
sudden death occurred in as many as 68% of cyan-
otic patients who were relatively stable prior to
sudden events (precipitated by strenuous exercise,
dehydration). Cantor et al. [9] reported heart failure
to be the cause of death in 48% of patients, sudden
cardiac death accounted for 20% fatalities, infective
endocarditis for 7%, major pulmonary bleeding for
7% and in 8% of cases the cause is undetermined.
It may suggest that investigators reporting their
findings also failed to gather complete data (out-of-
-hospital deaths) emphasising the difficulties of
drawing general conclusions with respect to the still
small population of adults with CHD. Methodology
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issues are also raised [2], and so continuous follow-
up of such patients and gathering data in co-opera-
tion with other investigators seems warranted.
Long-term follow-up data suggests that the
median life span of patients with CHD is significant-
ly shorter than in the general population [10, 11, 18].
Our findings confirm better survival in patients with
simple CHD. Complexity of the lesion was also
found to increase relative risk of death. A higher
incidence of clinical complications and the poten-
tial for increased mortality led Somerville [8] to
distinguish simple from complex lesions, a classifi-
cation also used in our study of adult patients.
Better survival was observed in all subjects in
our group who had undergone past surgical correction
of CHD. This obvious finding is confirmed in many
other reports. In patients with Marfan syndrome
receiving no surgical treatment, average life span
does not exceed 40 years, whereas after an opera-
tion those patients ususally reach the age of 60 [26].
According to published data, in patients after
successful surgery for the coarctation of the aorta,
84% survive at least 20 years and 72% for 30 years [6].
Such patients were quite numerous in our cohort.
Of survivors of ToF repair, more than 85% are alive
30 years after the operation [21].
Average survival in subjects operated on for
common atrio-ventricular canal depends on the ex-
tent of the procedure; in those without VSD closure,
82% reached the age of 32, with VSD repair only
70% lived that long [27].
If patients with DTGA are not operated on early
in life, very few reach the age of 20 [3, 7]. The post-
Mustard/Senning operation 20-year survival rate
has been reported at 76–80% [18].
The Fontana procedure is associated with 77–
–96% five-year, 60–81% ten-year and 55–76%
15-year survival [16, 22, 24]. However, in this group
of patients, operation is not an independent prog-
nostic factor of survival. There are patients with
simple CHD who haven’t been referred for surgery
who are haemodynamically stable and present with
normal heart function and blood oxygenation, rep-
resenting a benign form of the disease. At the same
time, there are patients with complex lesions
corrected several years earlier, who are in poor con-
dition, presenting with heart failure and cyanosis.
These two extreme clinical conditions predict out-
comes in the future irrespective of whether they
have been operated on.
There is no doubt that, generally speaking,
cardiac surgery improves survival for patients with
CHD. But in the heterogeneous population of such
patients, it is not the fact of being operated on, but
other clinical variables reflecting patient status at
baseline, that are good predictors of survival.
Our findings do not confirm age as a prognostic
factor of survival, as postulated in some reports [28].
It used to be said that ageing is never good for our
health. This is true for those born without congen-
ital disease. Individuals making up our cohort were,
however, affected from the very first moments of
their lives. Thus the natural or modified history of
the lesion has a much stronger impact on survival
than age per se.
In our cohort, gender was not found to be a risk
factor of death. Although gender has often been
included in models searching for potential predic-
tors of mortality, in most reports it has turned out
to be neutral [5, 9, 11]. Only a few studies have sug-
gested a significant role for gender in this aspect.
The unfavourable effect of male gender on survival
was reported in patients with Ebstein anomaly [29],
also in those who required permanent pacing [30].
Due to the increased risk of thromboembolic com-
plications associated with the use of hormone con-
taceptives, women with Eisenmenger syndrome are
believed to be at higher risk of death than men [5].
Conclusions
Heart failure and cyanosis are negative predic-
tors of survival in adult patients with CHD. Com-
plexity of the lesion increases the relative risk of
mortality. Cardiac surgery in the past is associated
with better survival, but, like age and gender, is not
a significant prognostic factor.
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